ARCHIVES

Continous Hormone Therapy Superior To Intermittent In 17-Year SWOG Study

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Calls Fisher “A Dominant Force” In Breast Cancer

September 5, 1997

Texts Of Workshop Report Summarized

November 8, 1996

Cancer Program Advocates Seek $170 Mil. Above President’s Budget, Vow To Close Bypass Gap

May 8, 1992

NIH Seeks Candidates For Research Grants Division Director

September 8, 1995

NCI Clinical Research Too Similar To Work By Extramural Community, Report Finds

July 21, 1995

Centocor Withdraws Yondelis After FDA Calls for New Study

April 29, 2011